LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-substituted steroids useful in cancer treatment

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.alpha. and 17.beta.-substituted estra-1,3,5(10)-triene-3-carb

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.alpha.-(substituted-methyl)-17.beta.-hydroxy/esterified hydro

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.alpha.-alkyl-17.beta.-hydroxy-1.alpha.-methyl-4-androsten-3-o

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.alpha.-cyanomethylestra-4,9-dien derivatives and pharmaceutic

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.alpha.-Pregn-4-ene-3-oxo-21-carboxylic acid esters, process f

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.beta.-(2-oxo-tetrahydrofuranyl)-thio- substituted androstane

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related com

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5.al

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.beta.-hydroxy-17.alpha.-methyl-5.alpha.-androstano[3,2-c]pyra

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.beta.-nitro-11.beta.-arylisteroids and their derivatives havi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.beta.-nitro-11.beta.-arylsteroids and their derivatives havin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17.beta.-nitro-11.beta.-arylsteroids and their derivatives havin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17a-hydroxy-4-androstene-3-one and derivatives thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

18 Norsteroids as selectively active estrogens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

18-Methyl-19-norandrost-4-ene 17, 17-spiro ether...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

19-hydroxyaldosterone and its preparation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

19-nor steroids having a thiocarbonated chain in position...